Raltitrexed plus Gemcitabine (TOMGEM) in advanced pancreatic cancer: Results of a Belgian Multicentre phase II study von VAN LAETHEM, J.-L, VAN MAELE, Ph, PEETERS, M, VERSLYPE, C, POLUS, M, DEMOLS, A, HOUBIERS, Gh, CAENEPEEL, P, LELEUX, A, VERMAUT, R. R, VAN CUTSEM, E

Volltext

Raltitrexed plus Gemcitabine (TOMGEM) in Advanced Pancreatic Cancer von van Laethem, J.-L., van Maele, Ph, Verslype, C., Polus, M., Demols, A., Houbiers, Gh, Caenepeel, P., Leleux, A., Vermaut, R.R., van Cutsem, E., Peeters, M.

Volltext